Clinical Trial Update: A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating SHR-A1904 for biliary tract cancer is currently recruiting after prior systemic treatment failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• SHR-A1904

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING